Objective: To determine the effectiveness and risks of non-image-guided lumbar interlaminar epidural steroid injections.
Design: Systematic review.
Interventions: Three reviewers with formal training and certification in evidence-based medicine searched the literature on non-image-guided lumbar interlaminar epidural steroid injections. A larger team of seven reviewers independently assessed the methodology of studies found and appraised the quality of the evidence presented.
Outcome Measures: The primary outcome assessed was pain relief. Other outcomes such as functional improvement, reduction in surgery rate, decreased use of opioids, and complications were noted, if reported. The evidence was appraised in accordance with the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system of evaluating evidence.
Results: The searches yielded 92 primary publications addressing non-image-guided lumbar interlaminar epidural steroid injections. The evidence supporting the effectiveness of these injections for pain relief and functional improvement in patients with lumbar radicular pain due to disc herniation or neurogenic claudication secondary to lumbar spinal stenosis is limited. This procedure may provide short-term benefit in the first 3-6 weeks. The small number of case reports on significant risks suggests these injections are relatively safe. In accordance with GRADE, the quality of evidence is very low.
Conclusions: In patients with lumbar radicular pain secondary to disc herniation or neurogenic claudication due to spinal stenosis, non-image-guided lumbar interlaminar epidural steroid injections appear to have clinical effectiveness limited to short-term pain relief. Therefore, in a contemporary medical practice, these procedures should be restricted to the rare settings where fluoroscopy is not available.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/pm/pnw091 | DOI Listing |
AJNR Am J Neuroradiol
December 2022
Department of Radiology (J.C.D., A.P.N.), University Hospitals Cleveland Medical Center, University Hospitals, Cleveland, Ohio
Background And Purpose: Referrals to perform fluoroscopy-guided lumbar punctures by neuroradiologists have increased. The purpose of our study was to determine the management of fluoroscopy-guided lumbar puncture referrals in different practice settings.
Materials And Methods: We sent an online questionnaire to neuroradiologists and radiology trainees between May and June 2020 to survey their handling of fluoroscopy-guided lumbar puncture requests, preprocedural work-up, and the use of physician extenders/trainees to perform fluoroscopy-guided lumbar punctures, among other questions.
J Neurol Surg A Cent Eur Neurosurg
January 2023
Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Background: Lower back pain is a frequent cause of emergency department visits and one of the leading causes of the disease burden worldwide. The purpose of this case report and literature review was to discuss atypical abdominal entities mimicking spinal diseases typically presenting with lower back pain.
Methods: A 79-year-old man presented with lower back pain and urinary incontinence after receiving a non-image-guided lumbar infiltration treatment 4 weeks prior to admission.
Eur J Radiol Open
December 2021
Department of Neuroradiology, A.O.R.N. Cardarelli, Naples, Italy.
Low back pain (LBP) is a common disorder affecting an increasing number of people worldwide, whose diagnosis is focused on the identification of triggering causes. First line therapy usually starts from conservative approaches, whereas second line treatments include a spectrum of minimally invasive techniques, before resorting to more invasive surgical approaches. Among minimally invasive techniques, percutaneous oxygen-ozone injections represent one of the most common and cost-effective procedures.
View Article and Find Full Text PDFDiagn Interv Radiol
November 2020
Division of Neuroradiology, Department of Radiology and the Department of Neurology, Division of Pediatric Neurology, Minnesota University, Minneapolis, USA.
Purpose: Nusinersen is a drug approved in December 2016 for treatment of spinal muscular atrophy (SMA). We want to share our initial experience with image-guided, non-image-guided, and port-delivered nusinersen injections in a large single-center SMA patient cohort, treating both pediatric and adult patients with focus on technical considerations and other patient concerns from a combined perspective of patient, neurologist, and radiologist.
Methods: All nusinersen injections between February 2017 and September 2018 were retrospectively reviewed.
Aerosp Med Hum Perform
January 2019
Changes of visual function/neuro-opthalmic structures during spaceflight have been described as visual impairment and intracranial pressure syndrome (VIIP)/spaceflight-associated neuro-ocular syndrome (SANS). Although theories are suggested, the mechanism is unknown. Only indirect measurements of intracranial pressure (ICP) have been performed in spaceflight.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!